The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab.
 
Inna Y Gong
No Relationships to Disclose
 
Sunil Verma
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Lilly; Novartis; Roche/Genentech
 
Andrew T Yan
Research Funding - AstraZeneca; Bristol-Myers Squibb; Sanofi
 
Dennis T Ko
No Relationships to Disclose
 
Craig Earle
Consulting or Advisory Role - UnitedHealthcare
Patents, Royalties, Other Intellectual Property - UpToDate
 
George A. Tomlinson
No Relationships to Disclose
 
Maureen E. Trudeau
Stock and Other Ownership Interests - RNA Diagnostics
Honoraria - Roche Canada
Consulting or Advisory Role - Nanostring/Innomar Strategies; RNA Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst)
Other Relationship - AstraZeneca; Eisai; Novartis; Roche Canada
 
Monika K. Krzyzanowska
Honoraria - Bayer; Eisai
Research Funding - AstraZeneca (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst)
Other Relationship - Bayer/Onyx
 
Christine Brezden-Masley
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech
 
Scott Gavura
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose